News

Congratulations to the recipients of the BC Cancer Foundation (BCCF) Rising Stars Graduate Awards competition!

This year’s awardees are: 

BC Cancer’s 2025 Cancer Emerging Multidisciplinary Research Programs supports research teams to initiate novel multidisciplinary research projects that aim to tackle well-defined issues or problems that affect patients living with cancer or at risk of developing cancer. Funding for the programs is provided through the BC Ministry of Health in collaboration with the BC Cancer Foundation.

2025 Emerging Multidisciplinary Research Programs Recipients: 

Each year, the UBC Faculty of Medicine (FoM) recognizes faculty members who have made exceptional contributions in the areas of education, research and/or service, and who are dedicated to advancing both the Faculty’s values and vision of transforming health for everyone.

Two BC Cancer researchers are recipients of the 2025 UBC FoM Distinguished Achievement Awards in the following categories: 

A new BC Cancer project has been shown to expedite the triaging of breast cancers and accelerate the initiation of treatment. 

The CAN-TRI-NLP, or a “CANcer TRIage system to expedite care with Natural Language Processing” project, was funded through the Ministry of Health's Innovation Pathway Program to explore a new expedited breast cancer triage system for faster initiation of appropriate treatment, chemotherapy or surgery.

In a world-first clinical trial, a team of international researchers working with the Canadian Cancer Trials Group (CCTG) have demonstrated that a structured exercise program significantly improves survival for colon cancer patients by reducing the risk of disease recurrence and new primary cancers.

The groundbreaking seventeen-year study involved researchers from UBC’s Faculty of Medicine as well as researchers at 55 sites across Canada, Australia and the United Kingdom.

British Columbia’s first dedicated inpatient clinical trials unit for early-phase therapies in blood cancers has been launched by Vancouver Coastal Health in collaboration with BC Cancer physicians and scientists. Located at Vancouver General Hospital (VGH), the new Hematology Research Unit will deliver revolutionary therapies — including first-in-human treatments such as advanced immunotherapies like CAR T-cell therapy — to patients with relapsed or treatment-resistant hematological diseases.